Companies: Orivas

Latest: Watch here for details of new products and services.

About Us: Pharmalicensing - Partnering solutions for the life sciences
Our Products: Overview; Partnering Search; Company Profiling; Deal Negotiation; PL Intelligence; Reports; Comparison
PL Intelligence: Overview; Industry news; Deals review; Press releases; Articles
Case Studies: See what others think about our service
Newsletter: Partnering update; Key reports; Subscribe
Quick Links: Profile now; Register now; Profiled companies; Featured events; Industry news; PR Newswire; Jobs
Contact Pharmalicensing: Send an email; Call us: +44 1904 520460; Request a callback
RSS Feeds: Keep up to date

Pharmalicensing
is a division of
UTEK Europe Ltd

Companies
Company details

Orivas

Orivas markets and sells branded prescription and OTC medicines in Women's health care, Dermatology, Oncology

The company in detail

Contact details

To view this information, you must subscribe to PL Intelligence.

Head office

Orivas
Jasinskio 16B
Vilnius
LT-01112
Lithuania

Contact head office

Related companies

Decision Resources Inc.

BiotechEast Co., Ltd. (Technology Partner)

Cancer Research Technology

Innocoll, Inc.

Ferndale Laboratories

Related categories

Industry sector: Academic/Research / Pharmaceutical; Biotechnology / Human therapeutics; Pharmaceutical / Prescription; Pharmaceutical / OTC/Non-Prescription; Pharmaceutical / Personal Care; Pharmaceutical / Pediatric
Therapeutic target: Dermatological / Acne; Dermatological / Fungal infection; Dermatological / Psoriasis; Dermatological / Eczema; Dermatological / Dermatological (other); Dermatological / Bacterial infection; Dermatological / Dermatitis, atopic; Dermatological / Wound healing; Dermatological / Alopecia; Dermatological / Burns; Dermatological / Chronic idiopathic urticaria; Dermatological / Dermatitis, allergic; Dermatological / Dermatosis; Dermatological / Ichthyosis; Dermatological / Keloids; Dermatological / Hyperkeratosis; Oncology / Polyps; Genito-urinary / Gender related medicine female / Gynecological disorder (other); Genito-urinary / Gender related medicine female / Amenorrhea; Genito-urinary / Gender related medicine male / Benign prostatic hypertrophy; Genito-urinary / Sexually transmitted diseases / Chlamydia; Genito-urinary / Gender related medicine female / Contraception, female; Genito-urinary / Gender related medicine male / Contraception, male; Genito-urinary / Gender related medicine female / Dysmenorrhea; Genito-urinary / Gender related medicine female / Dysoplasia, cervical; Genito-urinary / Gender related medicine female / Endometriosis; Genito-urinary / Gender related medicine female / Female arousal disorder; Genito-urinary / Sexually transmitted diseases / Genital warts; Genito-urinary / Sexually transmitted diseases / Gonorrhea; Genito-urinary / Gender related medicine male / Male erectile dysfunction; Genito-urinary / Gender related medicine female / Menopause; Genito-urinary / Gender related medicine female / Pelvic inflammatory disease; Genito-urinary / Gender related medicine female / Polycystic ovary syndrome; Genito-urinary / Gender related medicine female / Pregnancy; Genito-urinary / Gender related medicine male / Prostatitis; Genito-urinary / Sexually transmitted diseases / Sexually transmitted diseases (other); Genito-urinary / Gender related medicine female / Sjogren's syndrome; Genito-urinary / Gender related medicine female / Turner's syndrome; Genito-urinary / Sexually transmitted diseases / Venereal disease (other); Oncology / Cancer (other); Oncology / Anti-oxidant; Oncology / Bladder cancer; Oncology / Bone cancer; Oncology / Brain cancer; Oncology / Breast cancer; Oncology / Cervical cancer; Oncology / Colorectal cancer; Oncology / Stomach/Esophageal; Oncology / Head and neck cancer; Oncology / Kidney cancer; Oncology / Leukemia; Oncology / Liver cancer; Oncology / Lung cancer; Oncology / Lymphoma; Oncology / Ovarian cancer; Oncology / Pancreatic cancer; Oncology / Prostate cancer; Oncology / Skin cancer; Oncology / Testicular cancer; Oncology / Transplant; Oncology / Tumor (other); Oncology / Vaginal Cancer; Oncology / Treatments; Oncology / Cancer side effects; Oncology / Womb cancer; Oral Health / Aphthous ulcers; Oral Health / Dental disorder (other); Oral Health / Gingivitis; Oral Health / Herpes simplex virus type 1 (oral); Oral Health / Mouth disorder (other); Oral Health / Mucositis oral; Oral Health / Mucositis, Radiation-induced; Oral Health / Periodontal disease; Oral Health / Tooth decay; Oral Health / Gum disease; Other therapeutic / Iron excess

Clients in focus...

Get the Flash Player to see this rotator.

Press releases: Pharmalicensing current industry press releases.

Products:	Partnering Search	Company Profiling	Deal Negotiation	PL Intelligence	Reports	Comparision
In-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Out-licensing:	Latest records	Industry Sector	Therapeutic Target	Search	Profile your company	Pharma partnering
Companies:	Profiled companies	Industry Sector	Therapeutic Target	Geographic Location	Search	Add your company
Reports:	Biotechnology	Business Development	Management	Market & Sales	Medical Devices	Pharmaceuticals
Jobs:	Pharmaceutical jobs	Browse jobs	Search for jobs	Create your CV	Employer profiles	Post your jobs
Forums:	Talk to an expert	Industry Gossip	Business Development	What's new	Reports	Services
News:	Deals & Alliances	Development	Financial Results	Financings	Intellectual Property	Regulatory
Events:	Pharma events	Calendar	Organizers	Featured events	Search
Articles:	Business Development	Technologies	Events	Legal and regulatory	Therapeutic
Deals:	Industry Sector	Therapeutic Target	Deals Date	Search	Reports	Press releases
About us:	Our Audience	Case Studies	Newsletter	Careers	FAQ	Contact us